Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin resistance in gram-positive cocci.

Patrice Courvalin1

  • 1Unite des Agents Antibacteriens, Institut Pasteur, Paris, France. pcourval@pasteur.fr

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 3, 2005
PubMed
Summary

Vancomycin-resistant enterococci (VRE) emerged in 1988 and have rapidly spread globally. This review covers VRE resistance mechanisms, focusing on the VanA type, and discusses methicillin-resistant Staphylococcus aureus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of standardized automated rapid antimicrobial susceptibility testing of Enterobacterales-containing blood cultures: a proof-of-principle study.

The Journal of antimicrobial chemotherapy·2020
Same author

Co-occurrence of aminoglycoside and β-lactam resistance mechanisms in aminoglycoside- non-susceptible Escherichia coli isolated in the Zurich area, Switzerland.

International journal of antimicrobial agents·2020
Same author

Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper.

American journal of infection control·2020
Same author

Tentative breakpoints and areas of technical uncertainty for early reading automated disc diffusion for Enterobacterales.

The Journal of antimicrobial chemotherapy·2020
Same author

Antibiotic resistance: turning evolutionary principles into clinical reality.

FEMS microbiology reviews·2020
Same author

Structural characterization of aminoglycoside 4'-O-adenylyltransferase ANT(4')-IIb from Pseudomonas aeruginosa.

Protein science : a publication of the Protein Society·2020

Area of Science:

  • Microbiology and Infectious Diseases
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Vancomycin-resistant enterococci (VRE) first identified in 1988, rapidly disseminated worldwide.
  • VRE are a significant nosocomial pathogen, prevalent in healthcare settings globally.
  • Methicillin-resistant Staphylococcus aureus (MRSA) is another critical multidrug-resistant bacterium.

Purpose of the Study:

  • To review the mechanism of bacterial resistance to glycopeptides, exemplified by VanA type.
  • To discuss the genetic basis (transposon Tn1546) and spread of VanA-mediated resistance in enterococci.
  • To explore the diversity, regulation, evolution, and dissemination of MRSA.

Main Methods:

  • Literature review of scientific articles on vancomycin resistance in enterococci and MRSA.
  • Analysis of molecular mechanisms of glycopeptide resistance, including the VanA system.
  • Examination of epidemiological data on the spread of VRE and MRSA.

Main Results:

  • Vancomycin resistance in enterococci is primarily mediated by the VanA phenotype, encoded by transposon Tn1546.
  • The VanA system alters bacterial cell wall precursors, preventing vancomycin binding and action.
  • MRSA exhibits significant diversity and has evolved complex regulatory mechanisms for its resistance traits.

Conclusions:

  • The rapid global spread of VRE highlights the urgent need to understand resistance mechanisms.
  • The VanA type represents a well-characterized model for glycopeptide resistance in enterococci.
  • Understanding MRSA evolution and dissemination is crucial for controlling its spread in healthcare environments.

Related Experiment Videos